XOMA Royalty (XOMA) Cash from Financing Activities (2010 - 2026)

XOMA Royalty (XOMA) reported Cash from Financing Activities of -$7.6 million for Q1 2026, down 10.82% on a YoY basis from -$8.6 million in Q1 2025, and up 28.52% sequentially from -$10.7 million in Q4 2025.

XOMA Royalty (XOMA) Cash from Financing Activities (2010 - 2026) Analysis & Trends

XOMA Royalty (XOMA) has 17 years of Cash from Financing Activities data on file, last reported at -$7.6 million in Q1 2026.

  • For the quarter ending Q1 2026, Cash from Financing Activities fell 10.82% year-over-year to -$7.6 million; the trailing twelve-month figure through Mar 2026 stood at -$28.3 million (down 116.26% YoY), and the FY2025 full-year result was -$26.5 million, down 137.83% from the prior year.
  • Cash from Financing Activities rose to -$7.6 million in Q1 2026, from -$10.7 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $124.5 million in Q4 2023 to a low of -$10.7 million in Q4 2025.
  • A 5-year average of $4.8 million and a median of -$1.3 million in 2022 frame the typical range for Cash from Financing Activities.
  • Across the five-year window, Cash from Financing Activities jumped 9517.1% in 2023 and slumped 902.72% in 2025, its largest moves.
  • Tracing XOMA's Cash from Financing Activities over 5 years: stood at -$1.3 million in 2022, then jumped by 9517.1% to $124.5 million in 2023, then slumped by 100.86% to -$1.1 million in 2024, then tumbled by 902.72% to -$10.7 million in 2025, then grew by 28.52% to -$7.6 million in 2026.
  • Business Quant data shows XOMA's Cash from Financing Activities at -$7.6 million in Q1 2026, -$10.7 million in Q4 2025, and -$3.0 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 30.14 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 68.63 Mn
4 NuCana 279.75 Bn 279.75 Bn - 9,311.16
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -538.80 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -802.20 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 238.74 Mn
10 XOMA Royalty 478.42 Mn 412.34 Mn - -7.64 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -7.64 Mn
Mar 31, 2026 -7.64 Mn
Dec 31, 2025 -10.69 Mn
Dec 31, 2025 -10.69 Mn
Jun 30, 2025 -3.03 Mn
Jun 30, 2025 -3.03 Mn
Mar 31, 2025 -6.89 Mn
Mar 31, 2025 -6.89 Mn
Dec 31, 2024 -1.07 Mn
Dec 31, 2024 -1.07 Mn
Sep 30, 2024 -4.00 Mn
Sep 30, 2024 -4.00 Mn
Jun 30, 2024 -1.10 Mn
Jun 30, 2024 -1.10 Mn
Mar 31, 2024 -4.96 Mn
Mar 31, 2024 -4.96 Mn
Dec 31, 2023 124.49 Mn
Dec 31, 2023 124.49 Mn
Sep 30, 2023 -1.37 Mn
Sep 30, 2023 -1.37 Mn